RAMMF Stock - RAMM Pharma Corp.
Unlock GoAI Insights for RAMMF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products in Canada and internationally. It offers Epifractán, a cannabinoid pharmaceutical drug; XALEX 10, a prescription pharmaceutical formulation for the treatment of refractory epilepsy; and NettaLife, a cannabis-based product for pets. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.
Visit WebsiteEarnings History & Surprises
RAMMFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2022 | Sep 29, 2022 | — | — | — | — |
Latest News
Frequently Asked Questions about RAMMF
What is RAMMF's current stock price?
What is the analyst price target for RAMMF?
What sector is RAMM Pharma Corp. in?
What is RAMMF's market cap?
Does RAMMF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to RAMMF for comparison